Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
01 2019
Historique:
received: 27 05 2018
accepted: 10 10 2018
pubmed: 21 11 2018
medline: 18 6 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

Eastern equine encephalitis virus (EEEV) is a mosquito-transmitted alphavirus with a high case mortality rate in humans. EEEV is a biodefence concern because of its potential for aerosol spread and the lack of existing countermeasures. Here, we identify a panel of 18 neutralizing murine monoclonal antibodies (mAbs) against the EEEV E2 glycoprotein, several of which have 'elite' activity with 50 and 99% effective inhibitory concentrations (EC

Identifiants

pubmed: 30455470
doi: 10.1038/s41564-018-0286-4
pii: 10.1038/s41564-018-0286-4
pmc: PMC6294662
mid: NIHMS1509440
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Neutralizing 0
Antibodies, Viral 0
Epitopes 0
Viral Envelope Proteins 0
glycoprotein E2, equine encephalitis virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-197

Subventions

Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095436
Pays : United States

Références

PLoS Negl Trop Dis. 2010 Jul 13;4(7):e739
pubmed: 20644615
PLoS One. 2017 Jul 7;12(7):e0180486
pubmed: 28686653
N Engl J Med. 2018 Aug 9;379(6):557-566
pubmed: 30089069
Nat Med. 2008 Jan;14(1):25-7
pubmed: 18064037
J Virol. 2008 May;82(10):4920-30
pubmed: 18353963
J Gen Virol. 1986 Feb;67 ( Pt 2):377-80
pubmed: 3944588
Science. 2010 Aug 13;329(5993):811-7
pubmed: 20616231
Virol J. 2015 Sep 29;12:152
pubmed: 26420265
PLoS Pathog. 2013;9(4):e1003312
pubmed: 23637602
J Virol. 2014 Aug;88(15):8213-26
pubmed: 24829346
MAbs. 2014 May-Jun;6(3):718-27
pubmed: 24518197
Nature. 2018 May;557(7706):570-574
pubmed: 29769725
Emerg Infect Dis. 2016 Dec;22(12):2216-2217
pubmed: 27662563
J Virol. 2010 Oct;84(19):9775-82
pubmed: 20631130
Neurohospitalist. 2016 Jan;6(1):29-31
pubmed: 26740855
J Virol. 2017 Jun 26;91(14):
pubmed: 28468884
Am J Trop Med Hyg. 2018 May;98(5):1472-1477
pubmed: 29557336
Am J Trop Med Hyg. 1990 Apr;42(4):394-8
pubmed: 2158755
Arch Virol. 1996;141(11):2191-205
pubmed: 8973533
Virology. 1988 Jul;165(1):66-73
pubmed: 2455383
J Virol. 2014 Sep 1;88(17):9616-23
pubmed: 24920796
Cell. 2015 Nov 19;163(5):1095-1107
pubmed: 26553503
Virol J. 2015 Sep 30;12:154
pubmed: 26423229
Appl Microbiol Biotechnol. 2013 Jul;97(14):6359-72
pubmed: 23512478
J Immunol. 2012 Apr 1;188(7):2967-71
pubmed: 22371392
Vet Immunol Immunopathol. 2012 Aug 15;148(3-4):364-8
pubmed: 22824180
Cell Rep. 2015 Dec 22;13(11):2553-2564
pubmed: 26686638
PLoS Pathog. 2017 Sep 15;13(9):e1006643
pubmed: 28915259
J Virol. 2014 Feb;88(4):2035-46
pubmed: 24307590
Nature. 2010 Dec 2;468(7324):709-12
pubmed: 21124458
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16026-31
pubmed: 21896745
Proc Soc Exp Biol Med. 1987 Jan;184(1):56-63
pubmed: 3025890
Immunol Rev. 2012 Nov;250(1):180-98
pubmed: 23046130
Nature. 2010 Dec 2;468(7324):705-8
pubmed: 21124457
Arch Virol. 1994;139(1-2):173-81
pubmed: 7529989
J Virol. 2014 Dec;88(24):14364-79
pubmed: 25275138
Virology. 1988 Feb;162(2):346-53
pubmed: 2448952
J Virol. 1998 Sep;72(9):7357-66
pubmed: 9696832
J Virol. 2018 May 29;92(12):
pubmed: 29618651
J Gen Virol. 2006 Sep;87(Pt 9):2467-76
pubmed: 16894184
Vector Borne Zoonotic Dis. 2012 Oct;12(10):872-6
pubmed: 22835151
Virology. 1988 Sep;166(1):82-90
pubmed: 3413988
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10648-52
pubmed: 7479858
N Engl J Med. 2013 May 2;368(18):1670-3
pubmed: 23635048
Virology. 1995 Apr 20;208(2):662-71
pubmed: 7747437
Cell Host Microbe. 2015 Jul 8;18(1):86-95
pubmed: 26159721
EMBO J. 2011 Aug 09;30(18):3854-63
pubmed: 21829169
Virology. 1990 Mar;175(1):41-9
pubmed: 2309450

Auteurs

Arthur S Kim (AS)

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

S Kyle Austin (SK)

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Christina L Gardner (CL)

Center for Vaccine Research, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
United States Army Research Institute for Infectious Diseases, Fort Detrick, MD, USA.

Adam Zuiani (A)

Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Douglas S Reed (DS)

Center for Vaccine Research, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

Derek W Trobaugh (DW)

Center for Vaccine Research, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

Chengqun Sun (C)

Center for Vaccine Research, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

Katherine Basore (K)

Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Lauren E Williamson (LE)

Vanderbilt Vaccine Center, Department of Pediatrics, and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

James E Crowe (JE)

Vanderbilt Vaccine Center, Department of Pediatrics, and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Mark K Slifka (MK)

Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.

Daved H Fremont (DH)

Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.
Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.

William B Klimstra (WB)

Center for Vaccine Research, Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

Michael S Diamond (MS)

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.
Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.
Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.
The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH